retatrutide clinical trial results weight loss Eli Lilly's Phase 3 studies investigating retatrutide, the "triple-G" agonist, have found that long-term use can achieve substantial loss. Read about the work via the link in the comments retatrutide clinical trial benefits New

Battling addictive behavior is challenging overall, but can a known solution for one problem lead to lasting help for another

What is Glycolic Acid

They need to be prescribed appropriately, with tailored wraparound support alongside them, to ensure people can fully benefit and maintain weight loss for as long as possible when they stop taking the medication. More on GLP-1s: Something Grim Is Happening to People Who Go Off GLP-1s

The update comes soon after the World Health Organization updated its guidelines for obesity treatment, citing the combination of GLP-1 drugs, a healthy diet and exercise being integral for success among patients

The platform combines prescription medications with in-app support from clinicians to help you achieve your health goals